Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 2
2017 5
2018 3
2019 4
2020 4
2021 5
2022 2
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Human sirtuin 2 inhibitors, their mechanisms and binding modes.
Penteado AB, Hassanie H, Gomes RA, Silva Emery FD, Goulart Trossini GH. Penteado AB, et al. Among authors: goulart trossini gh. Future Med Chem. 2023 Feb;15(3):291-311. doi: 10.4155/fmc-2022-0253. Epub 2023 Mar 9. Future Med Chem. 2023. PMID: 36892013 Review.
Parasitic sirtuin 2 as an opportunity in drug discovery.
Gomes RA, Fornari E, Silva Rocha AC, Tripodi GL, Silva Emery FD, Goulart Trossini GH. Gomes RA, et al. Among authors: goulart trossini gh. Future Med Chem. 2021 Aug;13(16):1397-1409. doi: 10.4155/fmc-2021-0091. Epub 2021 Jun 30. Future Med Chem. 2021. PMID: 34189957 Review.
Advances and Challenges in Drug Design of PPARδ Ligands.
Maltarollo VG, Kronenberger T, Windshugel B, Wrenger C, Trossini GHG, Honorio KM. Maltarollo VG, et al. Among authors: trossini ghg. Curr Drug Targets. 2018;19(2):144-154. doi: 10.2174/1389450118666170414113159. Curr Drug Targets. 2018. PMID: 28413978 Review.
Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets.
Laureano de Souza M, Lapierre TJWJD, Vitor de Lima Marques G, Ferraz WR, Penteado AB, Henrique Goulart Trossini G, Murta SMF, de Oliveira RB, de Oliveira Rezende C Jr, Ferreira RS. Laureano de Souza M, et al. Among authors: henrique goulart trossini g. Expert Opin Ther Targets. 2023 Jul-Dec;27(10):911-925. doi: 10.1080/14728222.2023.2264512. Epub 2023 Oct 30. Expert Opin Ther Targets. 2023. PMID: 37772733 Review.
Use of machine learning approaches for novel drug discovery.
Lima AN, Philot EA, Trossini GH, Scott LP, Maltarollo VG, Honorio KM. Lima AN, et al. Among authors: trossini gh. Expert Opin Drug Discov. 2016;11(3):225-39. doi: 10.1517/17460441.2016.1146250. Expert Opin Drug Discov. 2016. PMID: 26814169 Review.
Antiplasmodial activity of sulfonylhydrazones: in vitro and in silico approaches.
Moura Gatti F, Gomes RA, da Fonseca AL, Cardoso Lima EJ, Vital-Fujii DG, Taranto AG, Pilla Varotti F, Goulart Trossini GH. Moura Gatti F, et al. Among authors: goulart trossini gh. Future Med Chem. 2021 Feb;13(3):233-250. doi: 10.4155/fmc-2020-0229. Epub 2020 Dec 9. Future Med Chem. 2021. PMID: 33295837
Convergent QSAR Models for the Prediction of Cruzain Inhibitors.
Gonçalves RB, Ferraz WR, Calil RL, Scotti MT, Trossini GHG. Gonçalves RB, et al. Among authors: trossini ghg. ACS Omega. 2023 Oct 13;8(42):38961-38982. doi: 10.1021/acsomega.3c03376. eCollection 2023 Oct 24. ACS Omega. 2023. PMID: 37901514 Free PMC article.
29 results